Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Safety outcomes of low versus high dose imatinib mesylate in patients with advanced, metastatic, or nonresectable gastrointestinal stromal tumors: A systematic review

Gastrointestinal Tract(2024)10.54844/git.2023.482Source: DataRank Database

Safety outcomes of low versus high dose imatinib mesylate in patients with advanced, metastatic, or nonresectable gastrointestinal stromal tumors: A systematic review is a research paper published in Gastrointestinal Tract (2024). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.36)OA: goldTopics (18)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Doreen Waldron Lechner ORCID,Barbara Tafuto ORCID,Marena A. Marucci ORCID

Live enrichment

PubMed:38699682 PMC:PMC11064882 OpenAlex:https://openalex.org/W4393587521

NCATS NIH HHS

Grant: UL1 TR003017

National Institutes of Health

Grant: 5UL1TR003017-03

New Jersey Alliance for Clinical Translational Science: NJ ACTS

FWCI

0.36

Citation Percentile

0.5%

Citation Trend

2025

goldLicense: cc-by-nc-sa

journalhttps://www.hksmp.com/journals/git/article/download/482/602

publisherhttps://www.hksmp.com/journals/git/article/download/482/602

publisherhttps://www.hksmp.com/journals/git/article/download/482/601

publisherhttps://www.hksmp.com/journals/git/article/download/482/603

journalhttps://doi.org/10.54844/git.2023.482

Fields of Study

Gastrointestinal Tumor Research and TreatmentGastrointestinal disorders and treatmentsGastrointestinal Bleeding Diagnosis and Treatment03 medical and health sciences0302 clinical medicine

Keywords

Imatinib mesylateMedicineImatinibStromal cellGiSTOncologyMesylateInternal medicineStromal tumorDosageGastrointestinal Stromal TumorsMetastatic And Nonresectable DiseasesArticle

Sustainable Development Goals

SDG 0: Good health and well-being